July 15, 2025 · Form 4 insider transaction
Megna Michael R bought 495 shares of Kiniksa Pharmaceuticals International, plc at $15.63 per share, a transaction worth $7.7K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 22 days after the transaction.
The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of January 16, 2025 to July 15, 2025. The acquisition of these shares was exempt pursuant to Rule 16b-3(e).